Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > new tweet - update on .4% clinical trial
View:
Post by wexworth on Dec 07, 2020 9:01am

new tweet - update on .4% clinical trial

things are moving quickly.
Comment by Pareto8020 on Dec 07, 2020 9:36am
That's what she said.  :)  Hopefully results and partner/distribution are announced in 2021.  Early 2021 would be preferred!
Comment by JohnFriesen on Dec 07, 2020 10:19am
This post has been removed in accordance with Community Policy
Comment by Crazydan on Dec 07, 2020 11:31am
It as already pass the human repeated insult patch test and cutaneous compatibility assessment. No report of any negative effect. So the only thing left is to see if it's really more effective.
Comment by wexworth on Dec 07, 2020 11:42am
asian markets want .4% and now one of the top global 10 giants wants first rights access. on the global front, this is going to get very interesting.
Comment by JohnFriesen on Dec 07, 2020 11:55am
This post has been removed in accordance with Community Policy
Comment by str8goods4achg on Dec 08, 2020 10:48am
It is a 12 week trial launched Oct 5th. My guess is we should see results published in Q1.
Comment by bazooka73 on Dec 07, 2020 9:46am
Things are moving. But I dont read quickly
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities